BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30726142)

  • 21. Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.
    Clark RE; Baxter JD; Aweh G; O'Connell E; Fisher WH; Barton BA
    J Subst Abuse Treat; 2015 Oct; 57():75-80. PubMed ID: 25997674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of Opioid Overdose.
    Babu KM; Brent J; Juurlink DN
    N Engl J Med; 2019 Jun; 380(23):2246-2255. PubMed ID: 31167053
    [No Abstract]   [Full Text] [Related]  

  • 23. Real-world changes in US health system hospital-based services following treatment with a prescription digital therapeutic for opioid use disorder.
    Velez FF; Colman S; Kauffman L; Anastassopoulos K; Murphy S; Maricich Y
    Hosp Pract (1995); 2021 Dec; 49(5):341-347. PubMed ID: 34275401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment.
    Wen H; Hockenberry JM; Borders TF; Druss BG
    Med Care; 2017 Apr; 55(4):336-341. PubMed ID: 28296674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone.
    Varghese SP; Kumari P; Wijegunaratne H; Yovankin T; Garlapati V; Koola MM
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31274259
    [No Abstract]   [Full Text] [Related]  

  • 27. Underused Weapon In the War on Addiction.
    Kelley T
    Manag Care; 2018 Jan; 27(1):15-17. PubMed ID: 29369763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.
    Mendelson J; Flower K; Pletcher MJ; Galloway GP
    Exp Clin Psychopharmacol; 2008 Oct; 16(5):435-41. PubMed ID: 18837640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
    Yan K
    N Engl J Med; 2017 Mar; 376(10):1000. PubMed ID: 28276662
    [No Abstract]   [Full Text] [Related]  

  • 30. Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
    Sigmon SC; Schwartz RP; Higgins ST
    N Engl J Med; 2017 Mar; 376(10):1000-1001. PubMed ID: 28273017
    [No Abstract]   [Full Text] [Related]  

  • 31. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
    Pena E; Ahmed S
    Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
    [No Abstract]   [Full Text] [Related]  

  • 32. Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care.
    Schackman BR; Merrill JO; McCarty D; Levi J; Lubinski C
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S247-53. PubMed ID: 17109311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder.
    Abraham AJ; Andrews CM; Grogan CM; Pollack HA; D'Aunno T; Humphreys K; Friedmann PD
    Psychiatr Serv; 2018 Apr; 69(4):448-455. PubMed ID: 29241428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
    Balhara YP
    J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
    [No Abstract]   [Full Text] [Related]  

  • 35. Opioid Use in Pregnancy.
    Killion MM
    MCN Am J Matern Child Nurs; 2017; 42(6):360. PubMed ID: 29049062
    [No Abstract]   [Full Text] [Related]  

  • 36. Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient.
    Book SW; Myrick H; Malcolm R; Strain EC
    Am J Psychiatry; 2007 Jun; 164(6):979. PubMed ID: 17541066
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of Buprenorphine to Treat Opioid Use Disorder.
    Bartholow LAM; Pope J
    J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication-Based Treatment to Address Opioid Use Disorder.
    Leshner AI; Dzau VJ
    JAMA; 2019 Jun; 321(21):2071-2072. PubMed ID: 31046072
    [No Abstract]   [Full Text] [Related]  

  • 39. Provision of Buprenorphine to Pregnant Women by For-Profit Clinics in an Appalachian City.
    Walker JJ; Olsen ME
    South Med J; 2018 Oct; 111(10):575-578. PubMed ID: 30285261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innovations in efforts to expand treatment for opioid use disorder.
    Sigmon SC
    Prev Med; 2019 Nov; 128():105818. PubMed ID: 31445112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.